Men with HIV are more likely to be prescribed dolutegravir than women
Women are much less likely to be prescribed the highly-effective HIV antiretroviral, dolutegravir (DTG), than men according to a study published in the Annals of Internal Medicine.
The study, led by Dr Matthew Romo, reviewed the medical records of 134,672 patients from ...